Press release
New report: Generic Oncology Drugs Market outlook for 2019 | Bayer Healthcare AG, Amgen, Teva Pharmaceutical Industries, Pfizer, Boehringer Ingelheim GmbH
A significant increase has been noted in the spending capacity for the development of cancer. More than one-third of the trials proposed by the manufacturers are aimed at offering personalized cancer treatments, which further propels the demand for generic oncology drugs. A host of these factors have contributed massively to the expansion of the generic oncology drugs market at the global level.
Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8961
According to a report, the global generic oncology market is poised to surpass a striking CAGR of 6% through 2028. Increasing inclination of individuals towards smoking and tobacco consumption is the chief cause of cancer. Secondary factors such as sedentary lifestyle, genetic causes, viral infections, carcinogens, and high consumption of junk food make the human body susceptible to cancer. Growing concerns of a high number of deaths occurring on the back of cancer have provoked the government authorities to take effective steps for preventing cancer.
Notable Developments in the Generic Oncology Drugs Market
Improvement in the cancer treatment drugs and therapies have been one of the most underlying aims of the pharmaceuticals and medical organizations operating at the global level. Consequently, generic oncology drugs have been utilized for innovating novel therapies and increasing the survival rates of patients.
Blood Cancer Immensely Contributes to the Growth of the Generic Oncology Drugs Market
Amongst the various types of cancer such as skin cancer, bladder cancer, bone cancer, eye cancer, gastrointestinal cancer, gynecological cancer, lung cancer, endocrine cancer, and blood cancer is accounted for generating the largest share for the generic oncology drugs market. Patients diagnosed with blood cancer seek complete treatment to this chronic disease, as a result of which excessive demand for generic oncology drugs is created. In addition to this, the high cost of the therapies and generic oncology drugs play a crucial role in the growing size of the generic oncology drugs market.
Recent Developments to Drive the Growth of the Generic Oncology Drugs Market
The key players involved in transforming the landscape of the generic oncology drugs market include Bayer Healthcare AG, Amgen, Teva Pharmaceutical Industries, Pfizer, Boehringer Ingelheim GmbH, AstraZeneca, Hoffmann-La Roche Ltd., Eli Lily and Company, ARIAD Pharmaceuticals, Inc., GlaxoSmithKline, CELGENE Corporation, Novartis AG, Johnson and Johnson, AbbVie Inc., Merck & Co., and Sanofi, among others.
A Methodology of this Report is Available upon Request @ https://www.futuremarketinsights.com/askus/rep-gb-8961
Out of these leading players, CELGENE, Novartis, and Roche have been procuring a considerable share in the generic oncology drugs market with a rich product portfolio and pipeline products aimed at treating cancer effectively.
Novartis AG applied smart strategies for channel integration like eCommerce with mobile application to fuel the sales at the retail stores. In addition to this, the company achieved a CE mark for its gene modifying therapy used for the treatment of blood cancer.
Pfizer Inc. has been focusing on the over 39 therapies, in order to fortify its product portfolio. In the year 2017, Glasdegib of Pfizer received the priority review from the U.S. FDA to treat myeloid leukemia. Post this, XTANDI of Pfizer as well received the FDA approval.
Generic Oncology Drugs Market Reports - Table of Contents
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Generic Oncology Drugs Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. PESTLE Analysis
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Regulatory Scenario
5. Key Inclusions
5.1. Generic Oncology Drugs Pipeline
6. North America Generic Oncology Drugs Market Analysis 2013–2017 and Forecast 2018–2028
6.1. Introduction
6.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
6.4. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2013-2017
6.4.1. Large Molecule
6.4.2. Small Molecule
6.5. Market Size (US$ Mn) Forecast By Molecule Type, 2018-2028
6.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013-2017
6.6.1. Oral
6.6.2. Parenteral
6.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2028
6.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013-2017
6.8.1. Hospital Pharmacy
6.8.2. Retail Pharmacy
6.8.3. Online Pharmacy
6.8.4. Managed Care Institutions
6.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018-2028
6.10. Drivers and Restraints: Impact Analysis
6.11. Market Attractiveness Analysis
6.11.1. By Country
6.11.2. By Molecule Type
6.11.3. By Route of Administration
6.11.4. By Distribution Channel
Request to Browse Report Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-8961
About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.
Contact Us
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Blog: http://keepfacts.com/
Web: https://www.futuremarketinsights.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New report: Generic Oncology Drugs Market outlook for 2019 | Bayer Healthcare AG, Amgen, Teva Pharmaceutical Industries, Pfizer, Boehringer Ingelheim GmbH here
News-ID: 1758131 • Views: …
More Releases from Future Market Insights
Global Pectin Market Poised for Steady Growth as Innovation, Sustainability, and …
The global pectin market is entering a dynamic growth phase, with its valuation projected to rise from USD 1,125.9 million in 2025 to USD 2,074.2 million by 2035, advancing at a CAGR of 6.3%. Unlike many markets driven by broad consumer preferences, the pectin industry's trajectory is fueled by technological advancements, targeted product development, and a rising demand for sustainable and natural solutions. Both established manufacturers and emerging players are…
Isomalto-oligosaccharide Market Poised for Growth as Health-Conscious Consumers …
The global Isomalto-oligosaccharide (IMO) market is entering a period of strong growth, fueled by changing dietary preferences, rising health awareness, and a surge in innovation among manufacturers. Valued at USD 86.8 million in 2025, the market is projected to nearly double, reaching USD 181.6 million by 2035 at a steady CAGR of 7.7%.
The momentum reflects a growing consumer shift toward healthier lifestyles, particularly as awareness around obesity, diabetes, and gut…
Ashwagandha Extract Market Set for Strong Growth, Driven by Health Awareness, Sc …
The global Ashwagandha Extract market is on a dynamic growth path, projected to rise from USD 815.7 million in 2025 to USD 1,787.2 million by 2035, achieving a CAGR of 8.2% over the forecast period. This momentum reflects a powerful convergence of consumer health awareness, scientific validation of Ashwagandha's benefits, and manufacturers-both established leaders and emerging players-introducing innovative formulations to capture growing demand.
The surge in demand comes at a time…
Taurine Market to Reach USD 954.8 Million by 2035, Backed by Expanding Use in He …
The global taurine market is on track for robust growth over the next decade, with demand rising from USD 476.4 million in 2025 to USD 954.8 million by 2035, representing a healthy CAGR of 7.2%. This expansion is fueled by taurine's growing role across health supplements, infant nutrition, functional foods, energy beverages, and pet health products.
Taurine, an amino acid long recognized for its cardiovascular, metabolic, and neurological benefits, is increasingly…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
